Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 1616781, 9 pages
http://dx.doi.org/10.1155/2016/1616781
Review Article

Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer

1Department of Hepatobiliary Surgery, First Affiliated Hospital, Xi’an Jiaotong University, Xi’an 710061, China
2Department of General Surgery, First Affiliated Hospital, Xi’an Jiaotong University, Xi’an 710061, China
3Department of General Surgery, Second Affiliated Hospital, Xi’an Jiaotong University, Xi’an 710004, China

Received 7 September 2015; Revised 28 November 2015; Accepted 7 December 2015

Academic Editor: Ahmed E. Abdel Moneim

Copyright © 2016 Lun Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. T. Lau, Z. X. Lin, and P. S. Leung, “Role of reactive oxygen species in brucein D-mediated p38-mitogen-activated protein kinase and nuclear factor-κB signalling pathways in human pancreatic adenocarcinoma cells,” British Journal of Cancer, vol. 102, no. 3, pp. 583–593, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. N. McCarthy, “Tumorigenesis: oncogene detox programme,” Nature Reviews Cancer, vol. 11, no. 9, pp. 622–623, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Li, Q. Ma, J. Li et al., “Hyperglycemia enhances the invasive and migratory activity of pancreatic cancer cells via hydrogen peroxide,” Oncology Reports, vol. 25, no. 5, pp. 1279–1287, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. P. Fruehauf and F. L. Meyskens Jr., “Reactive oxygen species: a breath of life or death?” Clinical Cancer Research, vol. 13, no. 3, pp. 789–794, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. C. R. Reczek and N. S. Chandel, “ROS-dependent signal transduction,” Current Opinion in Cell Biology, vol. 33, pp. 8–13, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Gorrini, I. S. Harris, and T. W. Mak, “Modulation of oxidative stress as an anticancer strategy,” Nature Reviews Drug Discovery, vol. 12, no. 12, pp. 931–947, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Trachootham, J. Alexandre, and P. Huang, “Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?” Nature Reviews Drug Discovery, vol. 8, no. 7, pp. 579–591, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. C. L. Quinlan, J. R. Treberg, I. V. Perevoshchikova, A. L. Orr, and M. D. Brand, “Native rates of superoxide production from multiple sites in isolated mitochondria measured using endogenous reporters,” Free Radical Biology and Medicine, vol. 53, no. 9, pp. 1807–1817, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. R. P. Brandes, N. Weissmann, and K. Schröder, “Nox family NADPH oxidases: molecular mechanisms of activation,” Free Radical Biology and Medicine, vol. 76, pp. 208–226, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Schieber and N. S. Chandel, “ROS function in redox signaling and oxidative stress,” Current Biology, vol. 24, no. 10, pp. R453–R462, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Fridovich, “Superoxide anion radical (O2·-), superoxide dismutases, and related matters,” The Journal of Biological Chemistry, vol. 272, no. 30, pp. 18515–18517, 1997. View at Publisher · View at Google Scholar
  12. J. Boonstra and J. A. Post, “Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells,” Gene, vol. 337, pp. 1–13, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. A. P. Wojtovich and T. H. Foster, “Optogenetic control of ROS production,” Redox Biology, vol. 2, no. 1, pp. 368–376, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Lemmon and J. Schlessinger, “Cell signaling by receptor tyrosine kinases,” Cell, vol. 141, no. 7, pp. 1117–1134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Afanas'ev, “Reactive oxygen species signaling in cancer: comparison with aging,” Aging and Disease, vol. 2, no. 3, pp. 219–230, 2011. View at Google Scholar · View at Scopus
  16. M. Donadelli, I. Dando, T. Zaniboni et al., “Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism,” Cell Death & Disease, vol. 2, no. 4, article e152, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Vurusaner, G. Poli, and H. Basaga, “Tumor suppressor genes and ROS: complex networks of interactions,” Free Radical Biology and Medicine, vol. 52, no. 1, pp. 7–18, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Bishayee, A. R. Khuda-Bukhsh, and S. O. Huh, “PLGA-loaded gold-nanoparticles precipitated with quercetin downregulate HDAC-Akt activities controlling proliferation and activate p53-ROS crosstalk to induce apoptosis in hepatocarcinoma cells,” Molecules and Cells, vol. 38, no. 6, pp. 518–527, 2015. View at Publisher · View at Google Scholar
  19. C. Jose, N. Bellance, and R. Rossignol, “Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma?” Biochimica et Biophysica Acta—Bioenergetics, vol. 1807, no. 6, pp. 552–561, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. S. S. Sabharwal and P. T. Schumacker, “Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?” Nature Reviews Cancer, vol. 14, no. 11, pp. 709–721, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. S. W. Kang, S. Lee, and E. K. Lee, “ROS and energy metabolism in cancer cells: alliance for fast growth,” Archives of Pharmacal Research, vol. 38, no. 3, pp. 338–345, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. E. C. Vaquero, M. Edderkaoui, S. J. Pandol, I. Gukovsky, and A. S. Gukovskaya, “Reactive oxygen species produced by NAD (P) H oxidase inhibit apoptosis in pancreatic cancer cells,” Journal of Biological Chemistry, vol. 279, no. 33, pp. 34643–34654, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. R. K. Gupta, A. K. Patel, N. Shah et al., “Oxidative stress and antioxidants in disease and cancer: a review,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 11, pp. 4405–4409, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Couto, N. Malys, S. J. Gaskell, and J. Barber, “Partition and turnover of glutathione reductase from saccharomyces cerevisiae: a proteomic approach,” Journal of Proteome Research, vol. 12, no. 6, pp. 2885–2894, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. K. M. Halprin and A. Ohkawara, “The measurement of glutathione in human epidermis using glutathione reductase,” Journal of Investigative Dermatology, vol. 48, no. 2, pp. 149–152, 1967. View at Google Scholar · View at Scopus
  26. J. E. Klaunig and L. M. Kamendulis, “The role of oxidative stress in carcinogenesis,” Annual Review of Pharmacology and Toxicology, vol. 44, pp. 239–267, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. Q. Kong, J. A. Beel, and K. O. Lillehei, “A threshold concept for cancer therapy,” Medical Hypotheses, vol. 55, no. 1, pp. 29–35, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Ramanathan, K.-Y. Jan, C.-H. Chen, T.-C. Hour, H.-J. Yu, and Y.-S. Pu, “Resistance to paclitaxel is proportional to cellular total antioxidant capacity,” Cancer Research, vol. 65, no. 18, pp. 8455–8460, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. R. F. Hwang, T. Moore, T. Arumugam et al., “Cancer-associated stromal fibroblasts promote pancreatic tumor progression,” Cancer Research, vol. 68, no. 3, pp. 918–926, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. M. V. Apte, S. Park, P. A. Phillips et al., “Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells,” Pancreas, vol. 29, no. 3, pp. 179–187, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Lei, X. Huo, W. Duan et al., “α-mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion,” Cancer Letters, vol. 347, no. 1, pp. 129–138, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Fiorini, M. Cordani, G. Gotte, D. Picone, and M. Donadelli, “Onconase induces autophagy sensitizing pancreatic cancer cells to gemcitabine and activates Akt/mTOR pathway in a ROS-dependent manner,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1853, no. 3, pp. 549–560, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Kong, G. Jia, Z.-X. Cheng et al., “Dihydroartemisinin enhances Apo2L/TRAIL-mediated apoptosis in pancreatic cancer cells via ROS-mediated up-regulation of death receptor 5,” PLoS ONE, vol. 7, no. 5, Article ID e37222, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Suzuki, M. Okada, K. Shibuya et al., “JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells,” Oncotarget, vol. 6, no. 1, pp. 458–470, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Wang, A. K. Mandal, H. Saito et al., “Arsenic and chromium in drinking water promote tumorigenesis in a mouse colitis-associated colorectal cancer model and the potential mechanism is ROS-mediated Wnt/β-catenin signaling pathway,” Toxicology and Applied Pharmacology, vol. 262, no. 1, pp. 11–21, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Liu, H. R. Rezvani, J. H. Back et al., “Inhibition of p38 MAPK signaling augments skin tumorigenesis via NOX2 driven ROS generation,” PLoS ONE, vol. 9, no. 5, Article ID e97245, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Ziech, I. Anestopoulos, R. Hanafi et al., “Pleiotrophic effects of natural products in ROS-induced carcinogenesis: the role of plant-derived natural products in oral cancer chemoprevention,” Cancer Letters, vol. 327, no. 1-2, pp. 16–25, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Yang, X. Wang, G. Contino et al., “Pancreatic cancers require autophagy for tumor growth,” Genes & Development, vol. 25, no. 7, pp. 717–729, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Yang and A. C. Kimmelman, “A critical role for autophagy in pancreatic cancer,” Autophagy, vol. 7, no. 8, pp. 912–913, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Almoguera, D. Shibata, K. Forrester, J. Martin, N. Arnheim, and M. Perucho, “Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes,” Cell, vol. 53, no. 4, pp. 549–554, 1988. View at Publisher · View at Google Scholar · View at Scopus
  41. V. T. H. B. M. Smit, A. J. M. Boot, A. M. M. Smits, G. J. Fleuren, C. J. Cornelisse, and J. L. Bos, “KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas,” Nucleic Acids Research, vol. 16, no. 16, pp. 7773–7782, 1988. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Ogrunc, R. Di Micco, M. Liontos et al., “Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation,” Cell Death & Differentiation, vol. 21, no. 6, pp. 998–1012, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Edderkaoui, P. Hong, E. C. Vaquero et al., “Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 289, no. 6, pp. G1137–G1147, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. M. G. Binker, A. A. Binker-Cosen, D. Richards, B. Oliver, and L. I. Cosen-Binker, “EGF promotes invasion by PANC-1 cells through Rac1/ROS-dependent secretion and activation of MMP-2,” Biochemical and Biophysical Research Communications, vol. 379, no. 2, pp. 445–450, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. M. G. Binker, A. A. Binker-Cosen, H. Y. Gaisano, R. H. de Cosen, and L. I. Cosen-Binker, “TGF-β1 increases invasiveness of SW1990 cells through Rac1/ROS/NF-κB/IL-6/MMP-2,” Biochemical and Biophysical Research Communications, vol. 405, no. 1, pp. 140–145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Sawai, H. Funahashi, Y. Okada et al., “Interleukin-1α enhances IL-8 secretion through p38 mitogen-activated protein kinase and reactive oxygen species signaling in human pancreatic cancer cells,” Medical Science Monitor, vol. 11, no. 10, pp. BR343–BR350, 2005. View at Google Scholar · View at Scopus
  47. W. Li, L. Cao, L. Han, Q. Xu, and Q. Ma, “Superoxide dismutase promotes the epithelial-mesenchymal transition of pancreatic cancer cells via activation of the H2O2/ERK/NF-κB axis,” International Journal of Oncology, vol. 46, no. 6, pp. 2613–2620, 2015. View at Publisher · View at Google Scholar
  48. R. Hiraga, M. Kato, S. Miyagawa, and T. Kamata, “Nox4-derived ROS signaling contributes to TGF-β-induced epithelial-mesenchymal transition in pancreatic cancer cells,” Anticancer Research, vol. 33, no. 10, pp. 4431–4438, 2013. View at Google Scholar · View at Scopus
  49. Y. Xi, Y. Wei, B. Sennino et al., “Identification of pY654-β-catenin as a critical co-factor in hypoxia-inducible factor-1α signaling and tumor responses to hypoxia,” Oncogene, vol. 32, no. 42, pp. 5048–5057, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Shimojo, M. Akimoto, T. Hisanaga et al., “Attenuation of reactive oxygen species by antioxidants suppresses hypoxia-induced epithelial-mesenchymal transition and metastasis of pancreatic cancer cells,” Clinical & Experimental Metastasis, vol. 30, no. 2, pp. 143–154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Liu, Q.-W. Ben, W.-Y. Yao et al., “BMP2 Induces PANC-1 cell invasion by MMP-2 overexpression through ROS and ERK,” Frontiers in Bioscience, vol. 17, no. 7, pp. 2541–2549, 2011. View at Google Scholar · View at Scopus
  52. S. Cannito, E. Novo, A. Compagnone et al., “Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells,” Carcinogenesis, vol. 29, no. 12, pp. 2267–2278, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. R. Mezencev, L. Wang, W. Xu et al., “Molecular analysis of the inhibitory effect of N-acetyl-L-cysteine on the proliferation and invasiveness of pancreatic cancer cells,” Anti-Cancer Drugs, vol. 24, no. 5, pp. 504–518, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Wu, S. Antony, S. M. Hewitt et al., “Functional activity and tumor-specific expression of dual oxidase 2 in pancreatic cancer cells and human malignancies characterized with a novel monoclonal antibody,” International Journal of Oncology, vol. 42, no. 4, pp. 1229–1238, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. H.-B. Cheng, Y. Bo, W.-X. Shen et al., “Longikaurin E induces apoptosis of pancreatic cancer cells via modulation of the p38 and PI3K/AKT pathways by ROS,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 388, no. 6, pp. 623–634, 2015. View at Publisher · View at Google Scholar
  56. J. Gong, A. R. Muñoz, D. Chan, R. Ghosh, and A. P. Kumar, “STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growth,” Oncotarget, vol. 5, no. 9, pp. 2529–2541, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Sakurai, M. Kudo, N. Fukuta et al., “Involvement of angiotensin II and reactive oxygen species in pancreatic fibrosis,” Pancreatology, vol. 11, no. 2, pp. 7–13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. J. J. Cullen, C. Weydert, M. M. Hinkhouse et al., “The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma,” Cancer Research, vol. 63, no. 6, pp. 1297–1303, 2003. View at Google Scholar · View at Scopus
  59. S. Y. Park, I. Chang, J.-Y. Kim et al., “Resistance of mitochondrial DNA-depleted cells against cell death: role of mitochondrial superoxide dismutase,” Journal of Biological Chemistry, vol. 279, no. 9, pp. 7512–7520, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. X. Deng, D. Z. Ewton, and E. Friedman, “Mirk/Dyrk1B maintains the viability of quiescent pancreatic cancer cells by reducing levels of reactive oxygen species,” Cancer Research, vol. 69, no. 8, pp. 3317–3324, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. G. M. DeNicola, F. A. Karreth, T. J. Humpton et al., “Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis,” Nature, vol. 475, no. 7354, pp. 106–109, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Kobayashi and M. Yamamoto, “Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species,” Advances in Enzyme Regulation, vol. 46, no. 1, pp. 113–140, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Zhou and Y. Du, “Acquisition of resistance of pancreatic cancer cells to 2-methoxyestradiol is associated with the upregulation of manganese superoxide dismutase,” Molecular Cancer Research, vol. 10, no. 6, pp. 768–777, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. D. Z. Ewton, J. Hu, M. Vilenchik et al., “Inactivation of Mirk/Dyrk1b kinase targets quiescent pancreatic cancer cells,” Molecular Cancer Therapeutics, vol. 10, no. 11, pp. 2104–2114, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. S. ten Raa, H. M. U. van Grevenstein, M. ten Kate et al., “The influence of reactive oxygen species on the adhesion of pancreatic carcinoma cells to the peritoneum,” Cell Adhesion & Migration, vol. 1, no. 2, pp. 77–83, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Ten Kate, A. G. J. Aalbers, W. Sluiter et al., “Polymorphonuclear leukocytes increase the adhesion of circulating tumor cells to microvascular endothelium,” Anticancer Research, vol. 27, no. 1, pp. 17–22, 2007. View at Google Scholar · View at Scopus
  67. M. ten Kate, J. B. C. van der Wal, W. Sluiter et al., “The role of superoxide anions in the development of distant tumour recurrence,” British Journal of Cancer, vol. 95, no. 11, pp. 1497–1503, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. D. Pathania, M. Sechi, M. Palomba et al., “Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer,” Biochimica et Biophysica Acta—General Subjects, vol. 1840, no. 1, pp. 332–343, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. X. Li, F. Zhu, J. Jiang et al., “Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in human pancreatic cancer cells,” Cancer Letters, vol. 357, no. 1, pp. 219–230, 2015. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Ghavami, M. Hashemi, S. R. Ande et al., “Apoptosis and cancer: mutations within caspase genes,” Journal of Medical Genetics, vol. 46, no. 8, pp. 497–510, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. W. Zhao, D. Li, Z. Liu, X. Zheng, J. Wang, and E. Wang, “Spiclomazine induces apoptosis associated with the suppression of cell viability, migration and invasion in pancreatic carcinoma cells,” PLoS ONE, vol. 8, no. 6, Article ID e66362, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. Z. Liu, D. Li, W. Zhao, X. Zheng, J. Wang, and E. Wang, “A potent lead induces apoptosis in pancreatic cancer cells,” PLoS ONE, vol. 7, no. 6, Article ID e37841, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. G. G. Mackenzie, L. Huang, N. Alston et al., “Targeting mitochondrial STAT3 with the novel phospho-valproic acid (MDC-1112) inhibits pancreatic cancer growth in mice,” PLoS ONE, vol. 8, no. 5, Article ID e61532, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. I. Dando, C. Fiorini, E. D. Pozza et al., “UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells,” Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, vol. 1833, no. 3, pp. 672–679, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. H. Q. Ju, T. Gocho, M. Aguilar et al., “Mechanisms of overcoming intrinsic resistance to gemcitabine in pancreatic ductal adenocarcinoma through the redox modulation,” Molecular Cancer Therapeutics, vol. 14, no. 3, pp. 788–798, 2015. View at Publisher · View at Google Scholar
  76. S.-H. Chen, D.-L. Li, F. Yang, Z. Wu, Y.-Y. Zhao, and Y. Jiang, “Gemcitabine-induced pancreatic cancer cell death is associated with MST1/Cyclophilin D mitochondrial complexation,” Biochimie, vol. 103, pp. 71–79, 2014. View at Publisher · View at Google Scholar · View at Scopus
  77. L. Li, G. G. L. Yue, J. X. Pu et al., “Eriocalyxin B-induced apoptosis in pancreatic adenocarcinoma cells through thiol-containing antioxidant systems and downstream signalling pathways,” Current Molecular Medicine, vol. 14, no. 5, pp. 673–689, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. S. Noori, Z. M. Hassan, and V. Farsam, “Artemisinin as a Chinese medicine, selectively induces apoptosis in pancreatic tumor cell line,” Chinese Journal of Integrative Medicine, vol. 20, no. 8, pp. 618–623, 2014. View at Publisher · View at Google Scholar · View at Scopus
  79. S. A. Curley, F. Palalon, X. Lu, and N. V. Koshkina, “Noninvasive radiofrequency treatment effect on mitochondria in pancreatic cancer cells,” Cancer, vol. 120, no. 21, pp. 3418–3425, 2014. View at Publisher · View at Google Scholar
  80. K. Larocque, P. Ovadje, S. Djurdjevic, M. Mehdi, J. Green, and S. Pandey, “Novel analogue of colchicine induces selective pro-death autophagy and necrosis in human cancer cells,” PLoS ONE, vol. 9, no. 1, Article ID e87064, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. Y. Xia, Q. Lei, Y. Zhu et al., “SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo,” Cancer Letters, vol. 355, no. 2, pp. 297–309, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. Y. Song, T. Baba, Y.-Y. Li et al., “Gemcitabine-induced CXCL8 expression counteracts its actions by inducing tumor neovascularization,” Biochemical and Biophysical Research Communications, vol. 458, no. 2, pp. 341–346, 2015. View at Publisher · View at Google Scholar · View at Scopus
  83. M. S. Wason, J. Colon, S. Das et al., “Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 9, no. 4, pp. 558–569, 2013. View at Publisher · View at Google Scholar · View at Scopus
  84. J. Wei, M. Liu, H. Liu et al., “Oleanolic acid arrests cell cycle and induces apoptosis via ROS-mediated mitochondrial depolarization and lysosomal membrane permeabilization in human pancreatic cancer cells,” Journal of Applied Toxicology, vol. 33, no. 8, pp. 756–765, 2013. View at Publisher · View at Google Scholar · View at Scopus
  85. D. Deeb, X. Gao, Y. Liu, N. R. S. Varma, A. S. Arbab, and S. C. Gautam, “Inhibition of telomerase activity by oleanane triterpenoid CDDO-Me in pancreatic cancer cells is ROS-dependent,” Molecules, vol. 18, no. 3, pp. 3250–3265, 2013. View at Publisher · View at Google Scholar · View at Scopus
  86. D. Deeb, X. Gao, Y. B. Liu, and S. C. Gautam, “Inhibition of cell proliferation and induction of apoptosis by CDDO-Me in pancreatic cancer cells is ROS-dependent,” Journal of Experimental Therapeutics & Oncology, vol. 10, no. 1, pp. 51–64, 2012. View at Google Scholar · View at Scopus
  87. B. Wang, X.-B. Wang, L.-Y. Chen, L. Huang, and R.-Z. Dong, “Belinostat-induced apoptosis and growth inhibition in pancreatic cancer cells involve activation of TAK1-AMPK signaling axis,” Biochemical and Biophysical Research Communications, vol. 437, no. 1, pp. 1–6, 2013. View at Publisher · View at Google Scholar · View at Scopus
  88. D. Li, Z. Liu, W. Zhao, X. Zheng, J. Wang, and E. Wang, “A small-molecule induces apoptosis and suppresses metastasis in pancreatic cancer cells,” European Journal of Pharmaceutical Sciences, vol. 48, no. 4-5, pp. 658–667, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. M. Khan, C. Ding, A. Rasul et al., “Isoalantolactone induces reactive oxygen species mediated apoptosis in pancreatic carcinoma PANC-1 cells,” International Journal of Biological Sciences, vol. 8, no. 4, pp. 533–547, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. Z. Liu, D. Li, L. Yu, and F. Niu, “Gallic acid as a cancer-selective agent induces apoptosis in pancreatic cancer cells,” Chemotherapy, vol. 58, no. 3, pp. 185–194, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. H.-Q. Duong, J. S. Hwang, H. J. Kim, Y.-S. Seong, and I. Bae, “BML-275, an AMPK inhibitor, induces DNA damage, G2/M arrest and apoptosis in human pancreatic cancer cells,” International Journal of Oncology, vol. 41, no. 6, pp. 2227–2236, 2012. View at Publisher · View at Google Scholar · View at Scopus
  92. M. Z. Hossainl and M. G. Kleve, “Nickel nanowires induced and reactive oxygen species mediated apoptosis in human pancreatic adenocarcinoma cells,” International Journal of Nanomedicine, vol. 6, no. 1, pp. 1475–1485, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. M. C. Messner and M. C. Cabot, “Cytotoxic responses to N-(4-hydroxyphenyl)retinamide in human pancreatic cancer cells,” Cancer Chemotherapy and Pharmacology, vol. 68, no. 2, pp. 477–487, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. P. Naumann, F. Fortunato, H. Zentgraf, M. W. Büchler, I. Herr, and J. Werner, “Autophagy and cell death signaling following dietary sulforaphane act independently of each other and require oxidative stress in pancreatic cancer,” International Journal of Oncology, vol. 39, no. 1, pp. 101–109, 2011. View at Publisher · View at Google Scholar · View at Scopus
  95. J.-H. Du, H.-D. Zhang, Z.-J. Ma, and K.-M. Ji, “Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo,” Cancer Chemotherapy and Pharmacology, vol. 65, no. 5, pp. 895–902, 2010. View at Publisher · View at Google Scholar · View at Scopus
  96. H. Zhou, L. Huang, Y. Sun, and B. Rigas, “Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling,” Cancer Letters, vol. 273, no. 2, pp. 292–299, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. R. P. Sahu, R. Zhang, S. Batra, Y. Shi, and S. K. Srivastava, “Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells,” Carcinogenesis, vol. 30, no. 10, pp. 1744–1753, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. W. Wang, M. Adachi, R. Zhang, J. Zhou, and D. Zhu, “A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells,” Pancreas, vol. 38, no. 4, pp. e114–e123, 2009. View at Publisher · View at Google Scholar · View at Scopus
  99. Y. Shi, R. P. Sahu, and S. K. Srivastava, “Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis,” BMC Cancer, vol. 8, no. 1, article 294, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. R. Zhang, I. Humphreys, R. P. Sahu, Y. Shi, and S. K. Srivastava, “In vitro and in vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway,” Apoptosis, vol. 13, no. 12, pp. 1465–1478, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. W. Sun, W. Wang, J. Kim et al., “Anti-cancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignment,” in Oxygen Transport to Tissue XXIX, vol. 614 of Advances In Experimental Medicine And Biology, pp. 179–186, Springer, New York, NY, USA, 2008. View at Publisher · View at Google Scholar